GlassScriptPhysician profile
David L Dinges
NPI 1366493165
$1,184.76
in general payments reported to CMS, 2019-2025
17 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $48.91 · 2021: $81.50 · 2022: $177 · 2023: $178 · 2024: $202 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.56 |
| Education | $123.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $364.01 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $257.68 | 2021-2025 | Dupixent |
| Medtronic, INC. | $85.73 | 2021-2023 | Ligasure |
| Intersect Ent, INC. | $84.09 | 2019-2021 | |
| Neurent Medical Limited | $83.92 | 2023-2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Alk-Abello, INC | $48.96 | 2019 | |
| Globus Medical, INC. | $43.47 | 2025 | Nvm5 |
| Merck Sharp & Dohme LLC | $34.50 | 2019-2023 | |
| Amgen INC. | $34.00 | 2025 | |
| Aerin Medical INC. | $30.41 | 2020-2024 | |
| Hikma Pharmaceuticals USA | $29.83 | 2023-2025 | Ryaltris |
| Stryker Corporation | $20.39 | 2019 | |
| Glaxosmithkline, LLC. | $17.53 | 2022 | |
| Ambu INC. | $14.98 | 2024 | |
| Shire North American Group INC | $12.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $11.54 | 2019 | |
| Smith+Nephew, INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dinges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.